Human-in-the-Loop AI drug discovery platform

Astellas says it has been integrating AI into drug development since 2019 and that its Human-in-the-Loop platform, which combines human expertise, AI and robotics, is widely used in small- and medium-molecule discovery. The article says that by leveraging AI, employees have cut the time to refine a hit compound into a drug candidate by approximately 70% compared with traditional methods.